Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Merck
Harvard Business School
Express Scripts
US Army
Cantor Fitzgerald
Mallinckrodt
Teva

Generated: May 20, 2018

DrugPatentWatch Database Preview

ERTACZO Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ertaczo patents expire, and when can generic versions of Ertaczo launch?

Ertaczo is a drug marketed by Valeant Luxembourg and is included in one NDA.

The generic ingredient in ERTACZO is sertaconazole nitrate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the sertaconazole nitrate profile page.
Summary for ERTACZO
Drug patent expirations by year for ERTACZO
Pharmacology for ERTACZO
Ingredient-typeAzoles
Drug ClassAzole Antifungal
Synonyms for ERTACZO
1-(2-((7-Chlorobenzo(b)thien-3-yl)methoxy)-2-(2
1-(2-((7-Chlorobenzo[b]thiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate
1-(2-((7-chlorobenzo[b]thiophen-3-yl)methylchlorobenzo[b]thiophen-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate
1-[2-[(7-chloranyl-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid
1-[2-[(7-Chloro-1-benzothien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate
1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid
1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid
1-[2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate
1-[2-[(7-chlorobenzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid
1H-Imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, mononitrate
1H-Imidazole, 1-[2-[(7-chlorobenzo[b]thien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-, nitrate
4-dichlorophenyl)ethyl)-1H-imidazole mononitrate
99592-32-2 (Parent)
99592-39-9
99592-39-9,99592-32-2(freebase)
A846049
AB0014376
AC-739
AC1L43NG
ACN-050915
AK468879
AKOS015888158
AKOS015964610
AN-15587
API0005086
AS-14332
C20H16Cl3N3O4S
CAS-99592-39-9
CCG-221045
CHEMBL1200725
CS-2960
D08510
Dermofix
Dermoseptic
Dermovit
DR003069
DSSTox_CID_25529
DSSTox_GSID_45529
DSSTox_RID_80932
DTXSID2045529
EBD2218183
Ertaczo (TN)
Extens
FI 7056
Fisderm
FT-0674558
Ginedermofix
HAAITRDZHUANGT-UHFFFAOYSA-N
HE421196
HMS1571A12
HMS2098A12
HMS2231N14
HMS3372H01
HY-B0736A
I01-0378
K784
LS-78268
MLS002154122
MolPort-005-940-278
NCGC00016966-01
NITRIC ACID; SERTACONAZOLE
Onabet
s3161
SCHEMBL261807
Sertaconazole (nitrate)
Sertaconazole mononitrate
Sertaconazole nitrate
SMR001233429
ST51051532
Tox21_110718
Zalain
Zalain (TN)

US Patents and Regulatory Information for ERTACZO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg ERTACZO sertaconazole nitrate CREAM;TOPICAL 021385-001 Dec 10, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Dow
Federal Trade Commission
Citi
UBS
Cipla
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.